Skip to main content

Table 2 CURB65 Severity for Pneumonia

From: Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii

Score

Risk

Disposition

0, or 1

1.5% mortality

Outpatient care

2

9.2% mortality

Inpatient vs observation admission

3

22% mortality

Inpatient admission with consideration for ICU admission with score of 4 or 5